Therapeutic use of immunoglobulins
- PMID: 21056739
- PMCID: PMC7112008
- DOI: 10.1016/j.yapd.2010.08.005
Therapeutic use of immunoglobulins
Figures
Similar articles
-
Subcutaneous immunoglobulin infusion to treat infants and toddlers with antibody deficiencies.Ann Allergy Asthma Immunol. 2010 Aug;105(2):187-8. doi: 10.1016/j.anai.2010.06.012. Ann Allergy Asthma Immunol. 2010. PMID: 20674834 No abstract available.
-
[Practical comments on the use of immunoglobulins].Pol Merkur Lekarski. 2011 Jun;30(180):448-51. Pol Merkur Lekarski. 2011. PMID: 21751557 Review. Polish.
-
The assessment and management of primary antibody deficiency.N Z Med J. 2004 Jun 4;117(1195):U914. N Z Med J. 2004. PMID: 15282626 Review. No abstract available.
-
New choices for treatment with subcutaneous immunoglobulins.Med Clin (Barc). 2017 Jan 20;148(2):86-90. doi: 10.1016/j.medcli.2016.09.037. Epub 2016 Dec 2. Med Clin (Barc). 2017. PMID: 27919413 Review. English, Spanish. No abstract available.
-
Immunoglobulin Replacement Therapy for Primary Immunodeficiency.Immunol Allergy Clin North Am. 2015 Nov;35(4):713-30. doi: 10.1016/j.iac.2015.07.006. Epub 2015 Sep 4. Immunol Allergy Clin North Am. 2015. PMID: 26454315 Review.
Cited by
-
Primary immunodeficiency diseases in lung disease: warning signs, diagnosis and management.Respir Res. 2018 Nov 12;19(1):219. doi: 10.1186/s12931-018-0923-8. Respir Res. 2018. PMID: 30419907 Free PMC article. Review.
-
II Brazilian Consensus on the use of human immunoglobulin in patients with primary immunodeficiencies.Einstein (Sao Paulo). 2017;15(1):1-16. doi: 10.1590/S1679-45082017AE3844. Einstein (Sao Paulo). 2017. PMID: 28444082 Free PMC article.
-
A clinician's guide for administration of high-concentration and facilitated subcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency diseases.Allergy Asthma Clin Immunol. 2022 Sep 30;18(1):87. doi: 10.1186/s13223-022-00726-7. Allergy Asthma Clin Immunol. 2022. PMID: 36180928 Free PMC article. Review.
-
Historical perspectives in the diagnosis and treatment of primary immune deficiencies.Clin Rev Allergy Immunol. 2014 Apr;46(2):101-3. doi: 10.1007/s12016-013-8384-9. Clin Rev Allergy Immunol. 2014. PMID: 23877724 Review.
-
Primary and Secondary Immunodeficiency Diseases in Oncohaematology: Warning Signs, Diagnosis, and Management.Front Immunol. 2019 Mar 26;10:586. doi: 10.3389/fimmu.2019.00586. eCollection 2019. Front Immunol. 2019. PMID: 30984175 Free PMC article.
References
-
- Lucey D. Anthrax. In: Mandel G., Bennett J.E., Donin R., editors. Principles and practice of infectious diseases. 6th edition. Elsevier/Churchill Livingston; Philadelphia: 2005. pp. 3618–3624. 2485–91.
-
- Gold H., Chester P.A. Studies on anthrax: clinical report of ten human cases. J Lab Clin Med. 1935;21:134–152.
-
- Cidrap HHS to buy 20,000 courses of anthrax antitoxin. cidrap.umn.edu/cidrap/content/bt/anthrax/news/jun2006anthrax.html Available at: Accessed June 20, 2006.
-
- Migone T., Subramanian M., Zhong J. Raxibacumab or the treatment of inhalational anthrax. N Engl J Med. 2009;361:135–144. - PubMed
-
- Stiehm E.R., Keller M.A. Passive immunization. In: Feigen R.D., Cherry J.D., Demmler-Harrison G.J., editors. Textbook of pediatric infectious diseases. 6th edition. Saunders/Elsevier; Philadelphia: 2009. pp. 3447–3479.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical